Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    7-Nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2(1H)-one

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,099Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    29/11/2025 Centaur Pharmaceuticals
    India
    		 CENTAUR PHARMACEUTICALS PRIVATE LIMITED Mumbai IN CEP 2006-030 - Rev 03 Clonazepam 2023-10-19 Valid Chemical 890
    29/11/2025 F.I.S. Fabbrica Italiana Sintetici
    Italy
    		 F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio Maggiore IT R1-CEP 2013-037 - Rev 01 Clonazepam, Non-micronised, micronised 2022-11-23 Valid Chemical 890